Skip to content

Impedance Cardiography During Major Abdominal Surgery

Comparison of Cardiac Output Derived From Flotrac/Vigileo and Impedance Cardiography During Major Abdominal Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01611376
Enrollment
11
Registered
2012-06-05
Start date
2012-09-30
Completion date
2013-02-28
Last updated
2013-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Surgery

Keywords

impedance cardiography, Flotrac/Vigileo, cardiac output

Brief summary

The investigators validated ICG's(impedance cardiography) usefulness during the abdominal surgery, by comparing it with FloTrac/Vigileo™ (Edwards Lifesciences,Irvine, CA, USA)

Detailed description

Intrathoracic structures have relatively constant resistance except the influence of changing diameter of aorta. Great vessels in thorax has the lowest resistance, and their diameter changes by the beats of the heart. As their diameter increases, their resistance decreases. ICG measures the difference between the resistances caused by heartbeats, and calculates cardiac output. But during the surgery, there are many interfering electrical currents made by electro cautery, patient positioning, and internal organ handling. Therefore, it has been thought that ICG is not a valid tool for measuring cardiac output during the surgery. The investigators validated ICG's usefulness during the surgery, by comparing it with Floctac/Vigileo.

Interventions

DEVICENiccomo™ (Medis, Ilmenau, Germany) impedance cardiography

Sponsors

Inje University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing open gastrectomy with arterial line * ASA 1 & 2

Exclusion criteria

* severe valve disease * severe lung disease

Design outcomes

Primary

MeasureTime frameDescription
Cardiac outputCardiac output will be measured using an ICG and compared with cardiac output measured using Flotrac/vigileo

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026